Disease/Infection News

RSS

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

30 Sep 2020

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

Scientists, policymakers and the media should acknowledge inherent uncertainties in epidemiological models projecting the spread of COVID-19 and avoid "catastrophizing" worst-case scenarios, according to new research from Cornell University.

30 Sep 2020

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

Researchers develop research model to understand the impact of coronavirus on lungs

Scientists at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) and the Center for Regenerative Medicine (CReM) joined forces to develop the most relevant research model possible for understanding how the coronavirus virus impacts the lungs, by engineering living, "breathing" human lung cells from stem cells for the task.

30 Sep 2020

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics. Since the beginning of COVID-19 outbreak the company has worked decisively on the development of SARS-CoV-2 diagnostics.

30 Sep 2020

Novel nasal treatment could protect people from COVID-19

A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.

30 Sep 2020

Survey: 37% of UK consumers say temperature checks are critical to COVID-19 safety

37 per cent of UK consumers have said that since the outbreak of COVID-19, they would be more likely to visit pubs, restaurants and hotels which have temperature checking in place for customer safety.

30 Sep 2020

Sleep apnea increases risk of severe COVID 19

Coronavirus disease (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A subset of COVID-19 patients face a severe form of the disease with hospitalization, respiratory failure, or death. Severe COVID-19 is primarily characterized by respiratory distress, and the common risk factors are older age, obesity, cardiovascular disease, diabetes, and poor lung function.

29 Sep 2020

College football crowds could impact COVID-19 spread

The observed increase in COVID-19 cases coinciding with the reopening of college campuses all over the US has drawn intense scientific attention. A recent paper, by Washington State University researchers, published on the preprint server medRxiv* in September 2020 reports that this threat is directly linked to the holding of in-person sporting events on these campuses.

29 Sep 2020

New graphical tool to identify potent neutralizing antibodies against SARS-CoV-2

A new study by researchers at the Indian Institute of Science and the University of Queensland and published on the preprint server medRxiv in September 2020 discusses using a novel tool to identify the most effective among currently known anti-SARS-CoV-2 NAbs.

29 Sep 2020

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.

29 Sep 2020

Genetic defects in patients' immune system may underlie severe COVID-19

Worldwide, otherwise healthy adolescents and young people without underlying conditions are sometimes severely affected by COVID-19, with the viral infection in the worst cases quickly becoming life-threatening. But why is this happening?

29 Sep 2020

Excessive social media use during COVID-19 related to depression and secondary trauma

Can't stop checking social media for the latest COVID-19 health information? You might want to take a break, according to researchers at Penn State and Jinan University who discovered that excessive use of social media for COVID-19 health information is related to both depression and secondary trauma.

29 Sep 2020

Intermittent fasting no better for weight loss than eating throughout the day, study finds

As more people become overweight and obese, diet crazes are becoming more popular than ever. One of the most popular diets today is intermittent fasting, an eating pattern that cycles between periods of fasting and eating. Previous studies have tied intermittent fasting to weight loss.

29 Sep 2020

Using AI and big data to predict the future spread of COVID-19 cases

During COVID-19, artificial intelligence (AI) has been used to enhance diagnostic efforts, deliver medical supplies and even assess risk factors from blood tests. Now, artificial intelligence is being used to forecast future COVID-19 cases.

29 Sep 2020

Ventilation systems may increase the risk of exposure to novel coronavirus

Ventilation systems in many modern office buildings, which are designed to keep temperatures comfortable and increase energy efficiency, may increase the risk of exposure to the coronavirus, particularly during the coming winter, according to research published in the Journal of Fluid Mechanics.

29 Sep 2020

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

The novel product, called INNA-051, is being developed by Ena Respiratory, and laboratory experiments have shown that it reduced viral replication by as much as 96 percent in the animal study. Spearheaded by Public Health England’s (PHE) Deputy Director, Professor Miles Carroll, the new study described the potential treatment and has been published in the open-source preprint server bioRxiv*.

29 Sep 2020

Case fatality rates for COVID-19 and health indicators

Researchers from Turkey and Switzerland collaborated to study the nation-specific case fatality rates for COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pandemic has affected around 33.5 million people worldwide and killed over 1 million making it one of the largest global health crises in recent memory.

29 Sep 2020

Disease/Infection News

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

COVID-19 has created a perfect storm for people with heart disease

COVID-19 has created a perfect storm for people with heart disease

Researchers develop research model to understand the impact of coronavirus on lungs

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Novel nasal treatment could protect people from COVID-19

Survey: 37% of UK consumers say temperature checks are critical to COVID-19 safety

Sleep apnea increases risk of severe COVID 19

College football crowds could impact COVID-19 spread

New graphical tool to identify potent neutralizing antibodies against SARS-CoV-2

Using new technology to study antibody responses in SARS-CoV-2-infected individuals

Genetic defects in patients' immune system may underlie severe COVID-19

Excessive social media use during COVID-19 related to depression and secondary trauma

Intermittent fasting no better for weight loss than eating throughout the day, study finds

Using AI and big data to predict the future spread of COVID-19 cases

Ventilation systems may increase the risk of exposure to novel coronavirus

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

Case fatality rates for COVID-19 and health indicators

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News